Rebecca Roylance, MD
About Rebecca Roylance, MD
Dr Rebecca Roylance is a medical oncologist specialising in the medical management of breast cancer, and is an honorary associate professor at University College London.
After qualifying from St Georges Hospital Medical School, she completed medical oncology training at UCLH and the Royal Free Hospital. She undertook a PhD at Imperial Cancer Research Fund (now Cancer Research UK) investigating the genetics of breast cancer before completing her specialist oncology training whilst a Cancer Research UK Clinician Scientist. Her laboratory work during this time continued at Cancer Research UK and focussed on the specific genetic changes occurring in low grade breast cancer. On completing her training she was awarded a HEFCE senior clinical fellowship and took up a consultant post at St Bartholomew’s Hospital, while continuing research into the genetic susceptibility of pre-invasive breast cancer and increasing her interest in translational work and clinical trials.
In 2015 she took up her current post as consultant oncologist at UCLH, where she is now the clinical lead for oncology.
She is active in clinical trials and sits on the Yorkshire Cancer Research Advisory Board. She is a senior medical editor for Macmillan.
She is currently the breast pathway director for the North Central London Cancer Alliance, having been the pathway director for London Cancer since 2012, the Integrated Cancer System for North Central and East London whose aims were to improve patient experience, and outcomes and increase recruitment to clinical trials.
